This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
What Awaits Intercontinental Exchange (ICE) in Q1 Earnings?
by Zacks Equity Research
Intercontinental Exchange (ICE) Q1 results are likely reflect increase in pricing of products, strong retention rate and growth in energy business.
What's in the Offing for CME Group (CME) This Earnings Season?
by Zacks Equity Research
CME Group's first-quarter revenues are likely to have benefited from clearing and transaction fees, market data and information services and other revenues, strong market position and varied derivative product lines.
The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, Texas Instruments, Caterpillar and Intercontinental Exchange
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, Texas Instruments, Caterpillar and Intercontinental Exchange
Can ICE (ICE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
ICE (ICE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Must-Buy Corporate Giants Ahead of Q1 Earnings Next Week
by Nalak Das
We have narrowed down our search to five corporate bigwigs slated to release first-quarter earnings results next week. These are: XOM, CVX, CAT, ICE and TXN.
IntercontinentalExchange (ICE) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
ICE (ICE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MarketAxess (MKTX) Q1 Earnings Miss Estimates by a Penny
by Zacks Equity Research
MarketAxess (MKTX) Q1 earnings reflect increase in revenues, partly offset by higher expenses and the effect of share buyback.
Nasdaq (NDAQ) Beats on Q1 Earnings & Revenues, Ups Dividend
by Zacks Equity Research
Nasdaq's (NDAQ) Q1 results reflect organic growth, favorable changes in foreign exchange rates, margin expansion and solid segmental performance.
Nasdaq's (NDAQ) to Report Q1 Earnings: What in the Cards?
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter results are likely to reflect benefits from its diversified product offerings and business model.
Cboe Global Markets (CBOE) Reports Mixed Q1 & March Volumes
by Zacks Equity Research
Cboe Global Markets (CBOE) reported mixed average daily volume (ADV) for the first quarter and March 2021
Intercontinental Exchange (ICE) Q1 & March Volumes Drop Y/Y
by Zacks Equity Research
Intercontinental Exchange (ICE) reported soft average daily volume (ADV) for the first quarter and March 2021.
Zacks Industry Outlook Highlights: Intercontinental Exchange, Nasdaq, MarketAxess Holdings, Cboe Global Markets and OTC Markets Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Intercontinental Exchange, Nasdaq, MarketAxess Holdings, Cboe Global Markets and OTC Markets Group
MarketAxess (MKTX) Reports Decline in March & Q1 Volume
by Zacks Equity Research
MarketAxess' (MKTX) business volumes for March reflect lower rates volume, partly offset by higher trading across U.S high-grade bonds and other credit bonds.
6 Securities and Exchanges Set to Benefit From Trading Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, NDAQ, MKTX, CBOE, CME, and OTCM. Compliance with regulations remains a challenge.
CME Group (CME) Q1 Volumes Drop Y/Y in All Product Lines
by Zacks Equity Research
CME Group (CME) reports ADV of 21.8 million contracts per day for first quarter of 2021, down 19% year over year due to lower volumes in all six product lines.
CME Group (CME) Gains From Transaction Fees, Faces Cost Woes
by Zacks Equity Research
CME Group (CME) is poised to grow riding on expanded products portfolio, non-transaction- related opportunities, OTC offerings, cross-sell through alliances, strong global presence and solid liquidity.
Here's Why You Should Retain Intercontinental (ICE) Stock
by Zacks Equity Research
Intercontinental Exchange (ICE) is poised to grow, attributable to growth in customer demand, growth in energy business, cash equities and demand for digital workflow tools.
ETF Strategies to Hedge Against Inflation
by Neena Mishra
Here are some ways to protect your portfolio from rising inflation.
ICE (ICE) Up 0.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
ICE (ICE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cboe Global (CBOE) Reports Mixed February Volumes, Shares Up
by Zacks Equity Research
Cboe Global Markets (CBOE) reported total average daily volume (ADV) of 13.4 million contracts in February, up 17.4% year over year.
Nasdaq (NDAQ) Reports Mixed February Volumes, Shares Gain
by Zacks Equity Research
Nasdaq (NDAQ) reported mixed volumes for February 2021. While U.S. equity options volume increased 53.5% year over year to 284 million contracts, European options and futures volume dropped 24.9% year over year to 6.9 million contracts
Intercontinental Exchange (ICE) February ADV Declines Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) February volumes reflect lower Agriculture and Metals ADV, Energy volume, Commodities ADV and Equity Index volume, partially offset by higher interest rate volume and foreign exchange volume.
MarketAxess (MKTX) February Trading Suggests Decent Volumes
by Zacks Equity Research
MarketAxess (MKTX) reports favorable business volumes for February, reflecting higher trading across major categories, such as U.S high-grade bonds and other credit bonds.
The Zacks Analyst Blog Highlights: Oracle, Medtronic, Advanced Micro Devices, Intercontinental Exchange and First Republic Bank
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Oracle, Medtronic, Advanced Micro Devices, Intercontinental Exchange and First Republic Bank
Top Stock Reports for Oracle, Medtronic & AMD
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Medtronic (MDT), and Advanced Micro Devices (AMD).